Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II study
- Resource Type
- Article
- Source
- In
eClinicalMedicine January 2024 67 - Subject
Primary Research Articles - Language
- ISSN
- 2589-5370